BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21224560)

  • 61. [Long-term survival after surgery and adjuvant imatinib in a patient with rectal GIST, local recurrence, liver metastases and mediastinal pleural metastasis].
    Tsutsui M; Yoshino S; Sakamoto K; Oka M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2351-3. PubMed ID: 20037419
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [A case of recurrent intestinal GIST with long-term survival-beneficial effect of multimodality therapy using high-dose imatinib and surgery].
    Akasaka H; Koyama M; Yokoyama H; Morohashi H; Sakamoto Y; Murata A; Hakamada K
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1975-7. PubMed ID: 23267948
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Repeated surgery improves survival in recurrent gastrointestinal stromal tumors: a retrospective analysis of 144 patients.
    Schurr P; Kohrs D; Reichelt U; Kaifi J; Vashist Y; Bachmann K; Bogoevski D; Yekebas E; Izbicki J
    Dig Surg; 2009; 26(3):229-35. PubMed ID: 19468233
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Curative resection for bulky rectal gastrointestinal stromal tumor after neoadjuvant imatinib mesylate].
    Kobayashi H; Uetake H; Higuchi T; Enomoto M; Yasuno M; Iida S; Yoshimura T; Ishikawa T; Ishiguro M; Kato S; Ono H; Kikuchi A; Yamauchi S; Sugihara K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2620-2. PubMed ID: 21224658
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations.
    Haller F; Detken S; Schulten HJ; Happel N; Gunawan B; Kuhlgatz J; Füzesi L
    Ann Surg Oncol; 2007 Feb; 14(2):526-32. PubMed ID: 17139461
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gastrointestinal stromal tumor: 5 years later.
    van der Zwan SM; DeMatteo RP
    Cancer; 2005 Nov; 104(9):1781-8. PubMed ID: 16136600
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Contemporary treatment of gastrointestinal stromal tumors].
    Nishida T
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1639-44. PubMed ID: 18931562
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Case of GIST of the rectum successfully treated with imatinib mesylate neoadjuvant therapy].
    Tsuchida K; Shiozawa M; Sugano N; Morinaga S; Akaike M; Sugimasa Y; Takemiya S; Kameda Y; Rino Y; Imada T
    Nihon Shokakibyo Gakkai Zasshi; 2008 Jun; 105(6):830-5. PubMed ID: 18525189
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Optimizing the dose of imatinib for treatment of gastrointestinal stromal tumours: lessons from the phase 3 trials.
    Patel S; Zalcberg JR
    Eur J Cancer; 2008 Mar; 44(4):501-9. PubMed ID: 18234488
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Surgery for gastrointestinal stromal tumour in the post-imatinib era.
    Neuhaus SJ; Clark MA; Hayes AJ; Thomas JM; Judson I
    ANZ J Surg; 2005 Mar; 75(3):165-72. PubMed ID: 15777399
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gastrointestinal stromal tumor.
    Gupta P; Tewari M; Shukla HS
    Surg Oncol; 2008 Aug; 17(2):129-38. PubMed ID: 18234489
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Clinical guidelines for the management of gastrointestinal stromal tumors].
    Lopez M; Comandone A; Adamo V; Apice G; Bearzi I; Bracci R; Carlini M; Carpano S; Condorelli S; Covello R; Cucchiara G; Di Filippo F; Doglietto GB; Ficorella C; Garofalo A; Gebbia N; Giuliani F; Massidda B; Messerini L; Palmirotta R; Tonelli F; Vidiri A
    Clin Ter; 2006; 157(3):283-99. PubMed ID: 16900856
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Current status of multidisciplinary treatment for advanced gastrointestinal stromal tumors].
    Kikuchi H; Ohta M; Konno H
    Nihon Shokakibyo Gakkai Zasshi; 2012 Dec; 109(12):2031-41. PubMed ID: 23221051
    [No Abstract]   [Full Text] [Related]  

  • 75. [More than 20 years of long-term survival case of intraabdominal GIST by combined therapies with frequent surgeries].
    Katayanagi S; Katsumata K; Murakoshi Y; Ogata T; Serizawa H; Tsuchida A; Aoki T; Shimazu M
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2322-4. PubMed ID: 21224560
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Current aspects of treatment in gastrointestinal stromal tumors (GIST)].
    Láng I; Hitre E
    Orv Hetil; 2005 May; 146(18 Suppl 1):935-41. PubMed ID: 15921308
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.